Chromia vs Injective — how do they compare? Chromia trades at Rp268.05 (market cap Rp258,71M, Rp33,78M 24h volume), while Injective trades at Rp86,066 (market cap Rp8,58T, Rp1,25T 24h volume). The key difference: Injective is far larger — about 33164.5× Chromia's market cap, and Chromia's supply is capped (974,8M / 978,1M CHR (100%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Chromia for 50 Days and Injective for 36 Days on average.
| CHR | INJ | |
|---|---|---|
Market Cap | Rp258,71M | Rp8,58T |
Volume (24h) | Rp33,78M | Rp1,25T |
Circulating Supply | 974,8M / 978,1M CHR (100%) | 100M INJ |
Typical Hold Time | 50 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
Chromia (CHR) trades at Rp268.43 with a market cap of Rp258.71M, showing neutral technical signals amid bearish moving averages. The token is fully circulated with a 50-day average hold time. Key support lies at Rp265 and resistance at Rp285. Recent ecosystem updates include mainnet progress and dApp integrations, though no major protocol upgrades were reported in the last month.
Outlook remains neutral with opportunities in blockchain adoption growth, but risks include high volatility and regulatory uncertainty. Investors should monitor trading volume trends and network activity for directional cues.
Injective (INJ) is trading at Rp86,314 with a market cap of Rp8.6T, showing bullish technical signals from moving averages while oscillators remain neutral. The token is currently positioned between key support at Rp86,075 and resistance at Rp89,928, with an average hold time of 36 days indicating moderate investor patience. Recent technical momentum suggests potential upward movement if it can break through the immediate resistance level.
Overall outlook remains cautiously optimistic with technical strength supporting potential gains, though the neutral oscillator readings suggest consolidation may precede further movement. Key opportunities include the bullish moving average alignment and strong support levels, while risks involve typical crypto volatility and the need for sustained volume to confirm the bullish trend.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Chromia is a standalone Layer-1 blockchain and EVM compatible Layer-2 enhancement for Binance Smart Chain and Ethereum. It is designed to enhance existing dApps and allow for the creation of next-generation dApps by providing scalability, improved data handling, and customizable fee structures. The blockchain uses a unique architecture called relational blockchain, as well as a custom programming language called Rell.
Read more on CHR →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →